Literature DB >> 12914886

Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).

Sidney Goldstein1, Prakash Deedwania, Stephen Gottlieb, John Wikstrand.   

Abstract

A subgroup analysis was performed in black patients who participated in the Metoprolol CR/XL Randomized Intervention trial in Congestive Heart Failure trial. Results suggest a beneficial effect of beta blockade and support the use of beta blockers in black patients with clinically stable heart failure and left ventricular dysfunction.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12914886     DOI： 10.1016/s0002-9149(03)00674-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Beta blocker therapy in African American patients with heart failure.

Authors:  Sidney Goldstein
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

Review 2.  Beta-blocker contraindications: are there patients or situations where use is inappropriate?

Authors:  S D Naik; Ronald S Freudenberger
Journal:  Curr Heart Fail Rep       Date:  2007-06

3.  Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.

Authors:  David E Lanfear; Tara N Hrobowski; Edward L Peterson; Karen E Wells; Tanmay V Swadia; John A Spertus; L Keoki Williams
Journal:  Circ Heart Fail       Date:  2012-01-19       Impact factor: 8.790

Review 4.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

Review 5.  Race, common genetic variation, and therapeutic response disparities in heart failure.

Authors:  Mathew R Taylor; Albert Y Sun; Gordon Davis; Mona Fiuzat; Stephen B Liggett; Michael R Bristow
Journal:  JACC Heart Fail       Date:  2014-10-22       Impact factor: 12.035

Review 6.  Beta-blockers in selected heart failure populations.

Authors:  Jalal K Ghali
Journal:  Curr Heart Fail Rep       Date:  2005-08

7.  Race and Beta-Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self-Reported Race and Proportion of African Genetic Ancestry.

Authors:  Jasmine A Luzum; Edward Peterson; Jia Li; Ruicong She; Hongsheng Gui; Bin Liu; John A Spertus; Yigal M Pinto; L Keoki Williams; Hani N Sabbah; David E Lanfear
Journal:  J Am Heart Assoc       Date:  2018-05-08       Impact factor: 5.501

Review 8.  Heart failure in sub-Saharan Africa.

Authors:  Gerald S Bloomfield; Felix A Barasa; Jacob A Doll; Eric J Velazquez
Journal:  Curr Cardiol Rev       Date:  2013-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.